Balyasny Asset Management’s Ventyx Biosciences VTYX Stock Holding History

Balyasny Asset Management’s Portfolio VTYX Stock Details VTYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-735,711	Closed	-$6.64M	–	3589
2025 Q4	$6.64M	Buy	+735,711	New	+$5.5M	0.01%	1238
2024 Q2	–	Sell	-11,480	Closed	-$63.1K	–	3158
2024 Q1	$63.1K	Buy	+11,480	New	+$52.5K	﹤0.01%	2517
2023 Q4	–	Sell	-217,151	Closed	-$7.54M	–	2953
2023 Q3	$7.54M	Buy	+217,151	New	+$7.51M	0.02%	950
2023 Q2	–	Sell	-423,404	Closed	-$14.2M	–	2846
2023 Q1	$14.2M	Buy	+423,404	New	+$16.5M	0.04%	641

Other funds holding VTYX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Balyasny Asset Management's VTYX Position: Q1 2026 in Review

Balyasny Asset Management sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 735,711 shares — an estimated $6.64M sold.

Balyasny Asset Management first reported a position in VTYX in Q1 2023 and held it in 4 quarters. The position peaked at $14.2M in Q1 2023. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.

Balyasny Asset Management reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
Balyasny Asset Management sold 735,711 Ventyx Biosciences shares in Q1 2026, an estimated $6.64M.
Balyasny Asset Management first reported a position in Ventyx Biosciences in Q1 2023 and held it in 4 quarters.
Balyasny Asset Management's Ventyx Biosciences position peaked at $14.2M in Q1 2023.
1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.